Drs Catherine Larochelle, Alexandre Prat & Nathalie Arbour

Neuroimmune mechanisms in MS and their clinical relevance from a neuropathological perspective Dr Imke Metz Institute of Neuropathology, University Medical Center Göttingen, Germany

Phenotyping immune cell-derived extracellular vesicles in MS provides novel insights into potential disease mechanisms and biomarker discovery Dr Craig Moore Memorial University, St. John's NL Canada

Immune Mediated Remodeling of Damaged CNS Vasculature Dr Dorian McGavern National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA

The central nervous system at risk – interaction with the immune system Dr Frauke Zipp Rhine-Main Neuroscience Network, University Medical Center of the Johannes Gutenberg University, Mainz, Germany

Improving the lesion microenvironment for remyelination Dr V. Wee Yong University of Calgary, Calgary, AB, Canada

The interleukin-1 cytokine system mediates neuroinflammation and pain in MS Dr Steve Lacroix Centre de recherche du CHU de Québec-Université Laval, Québec, QC, Canada

The inflammasome/pyroptosis axis in progressive MS Dr Christopher Power University of Alberta, Edmonton, Alberta Canada

Grey Matters: B cells, Ageing and MS Dr Jennifer Gommerman University of Toronto, Toronto, ON, Canada

The T cell/Phagocyte interface in NeuroinflammationThe T cell Dr Burkhard Becher University of Zurich, Institute of Experimental Immunology, Zurich, Switzerland

La Scena Quai Jacques-Cartier (in front of Place Jacques-Cartier) Montréal, QC, H2Y 4B2